- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2183EUR$2,500USD£1,897GBP
- Report
- December 2024
- 152 Pages
Global
From €3450EUR$3,950USD£2,997GBP
- Report
- September 2025
- 177 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 194 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2620EUR$3,000USD£2,276GBP
- Report
- August 2025
- 136 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- April 2025
- 186 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- May 2025
- 196 Pages
Global
From €4148EUR$4,750USD£3,604GBP
- Report
- January 2025
- 105 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- July 2025
- 82 Pages
United States
From €3057EUR$3,500USD£2,655GBP
- Report
- May 2025
- 120 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 184 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 150 Pages
Global
From €2489EUR$2,850USD£2,162GBP
€3362EUR$3,850USD£2,921GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more